Business Litigation

Complex Business Litigation Attorneys

Directors and officers occupy positions of trust in relation to the corporation and its shareholders, and are presumed to act in good faith and exercise honest judgment in the lawful and legitimate furtherance of corporate purposes.  The most common claims we prosecute are claims for (i) breach of fiduciary duty, (ii) usurpation of corporate opportunities and self-dealing, and (iii) waste of corporate assets.  In connection with prosecuting these claims, we litigate coverage matters related to directors’ and officers’ liability insurance policies. Claims against officers and directors may be direct or derivative.  Shareholders may bring direct claims against corporate directors and officers for injury to the shareholders, and under certain circumstances, may petition to dissolve the corporation.  Shareholders may also bring a class action for direct claims against the directors and officers, where the directors and officers have taken actions that affect shareholders with common characteristics.  Unlike these direct claims, shareholders may also sue derivatively, i.e., on behalf of the corporation for injury sustained to the corporation.  Here, the claims belong to the corporation – not the shareholders.  Derivative litigation is a unique species of corporate litigation, and is subject to special pleading and standing rules.
Navigating the EPA’s Climate Rollback: A Guide for Impacted Communities

In February 2026, the Environmental Protection Agency (EPA) formally rescinded the 2009 Greenhouse Gas Endangerment Finding, which had served as the scientific and legal foundation for nearly two...

Read the Article
3.2 Million Weber Grill Brushes & 10.2 Million Nexgrill Brushes Recalled: What Consumers Need to Know About Their Hidden Danger

Millions of Metal Wire Grill Brushes Recalled After Reports of Swallowed Metal Bristles Resulting in Serious Injuries  Outdoor grilling is a staple in many American households, but a recent nationwide...

Read the Article
A New MDL Takes Aim at Ozempic and Wegovy: What Patients with Vision Loss Need to Know

By Christopher R. LoPalo, Partner, and Silvino Díaz, Junior Partner Millions of Americans take Ozempic, Wegovy, or other GLP-1 receptor agonist (GLP-1 RA) medications to manage type 2...

Read the Article

Our Locations

Please Contact Us for an In-Person Appointment